References
1. International Conference on Harmonization. Q2(R1), Validation of analytical procedures: text and methodology. Geneva,
Switzerland; 2005, Nov.
2. The Fitness for Purpose of Analytical Method, Eurachem Teddington, UK; 1998.
http://www.eurachem.ul.pt/guides/valid.pdf
3. Traceability in Chemical Measurement, Eurachem/CITAC. Teddington, UK; 2003.
http://www.eurachem.ul.pt/guides/ EC_Trace_2003.pdf .
5. US Food and Drug Administration. Draft guidance for industry. Analytical procedures and methods validation. Rockville,
MD; 2000.
6. Parenteral Drug Association. Technical Report 33, evaluation, validation and Implementation of new microbiological testing
methods. Bethesda, MD.
7. European Pharmacopeia. Alternative methods for control of microbiological quality. Supplement 5.5 [07/2006:50106] (December
2005).
8. Krause SO. Validation of analytical methods for biopharmaceuticals—A guide to risk-based validation and implementation
strategies. PDA/DHI Publishing; 2007, Apr.
9. US Food and Drug Administration. Guidance for industry PAT—A framework for innovative pharmaceutical development, manufacturing,
and quality assurance, Rockville, MD; 2004.
10. ISPE Good Practice Guide: Technology Transfer. International Society for Pharmaceutical Engineering. 2003; Tampa, FL.
11. Statistical Principles for Clinical Trials, ICH E9 (1998).
http://www.emea.eu.int/ pdfs/human/ich/036396en.pdf.
12. Points to Consider on Switching Between Superiority and Non-Inferiority, CPMP (2000).
http://www.emea.eu.int/pdfs/ human/ewp/ 048299en.pdf.
13. Points to Consider On The Choice Of Non-Inferiority Margin, CPMP (2004).
|
